{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T23:36:43Z","timestamp":1792798603475,"version":"4.5.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T00:00:00Z","timestamp":1698710400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003710","name":"Korea Health Industry Development Institute","doi-asserted-by":"publisher","award":["HI21C0012"],"award-info":[{"award-number":["HI21C0012"]}],"id":[{"id":"10.13039\/501100003710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Neurosci"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Tic disorder is a neuropsychiatric condition that affects 3% of all children and can have a significant impact on their quality of life. Cytokines, interferons, interleukins, lymphokines, and tumor necrosis factors are involved in the neuroinflammatory circuitry of tic disorders. This study aimed to identify the cytokines involved in the pathogenesis of tic disorders. We enrolled 44 patients with tic disorder and 38 healthy controls. Patients were free of psychotropic medications for at least 3 weeks. Whole blood samples were analyzed using a Luminex\u00ae human cytokine multiplex assay kit. Patients were divided into groups with \u201cmild tics\u201d and \u201cabove moderate tics\u201d based on Yale Global Tic Severity Scale (YGTSS) scores for comparison. The final analysis included 35 patients (28 male and 7 female) and 31 controls (20 male and 11 female). In the mild tic group, interleukin (IL)-12 p70 negatively correlated with motor tic scores. Granulocyte-macrophage colony-stimulating factor, IL-4, IL-8, and tumor necrosis factor (TNF)-\u03b1 were positively correlated to phonic tic scores. IL-12 p40 and TNF-\u03b1 were positively correlated to total tic scores. IL-12 p70 and IL-17a negatively correlated to impairment scores and total YGTSS scores. Tic disorder patients and healthy controls exhibit different cytokine profiles. Only patients with mild symptoms exhibit significant correlations, suggesting that the correlations between cytokine levels and tic symptoms are more relevant during the mild or remission phases. Our results present the importance of IL-1\u03b2 and TNF-\u03b1, among others, but the identification of key cytokines are still necessary.<\/jats:p>","DOI":"10.1186\/s12868-023-00830-3","type":"journal-article","created":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T06:02:31Z","timestamp":1698732151000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Cytokine levels reflect tic symptoms more prominently during mild phases"],"prefix":"10.1186","volume":"24","author":[{"given":"SuHyuk","family":"Chi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Eun","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeong-An","family":"Gim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changsu","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moon-Soo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,10,31]]},"reference":[{"key":"830_CR1","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.pediatrneurol.2012.05.002","volume":"47","author":"T Knight","year":"2012","unstructured":"Knight T, Steeves T, Day L, Lowerison M, Jette N, Pringsheim T. Prevalence of tic disorders: a systematic review and meta-analysis. Pediatr Neurol. 2012;47:77\u201390. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2012.05.002.","journal-title":"Pediatr Neurol"},{"key":"830_CR2","doi-asserted-by":"publisher","first-page":"21","DOI":"10.23838\/pfm.2020.00191","volume":"5","author":"YS Joung","year":"2021","unstructured":"Joung YS, Lee MS. The therapeutic approaches in children and adolescent with Tourette\u2019s disorder. Precis Future Med. 2021;5:21\u201330. https:\/\/doi.org\/10.23838\/pfm.2020.00191.","journal-title":"Precis Future Med"},{"key":"830_CR3","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1176\/ajp.155.2.264","volume":"155","author":"SE Swedo","year":"1998","unstructured":"Swedo SE, Leonard HL, Garvey M, Mittleman B, Allen AJ, Perlmutter S, et al. Pediatric autoimmune Neuropsychiatric Disorders associated with streptococcal Infections: clinical description of the first 50 cases. Am J Psychiatry. 1998;155:264\u201371. https:\/\/doi.org\/10.1176\/ajp.155.2.264.","journal-title":"Am J Psychiatry"},{"key":"830_CR4","doi-asserted-by":"publisher","first-page":"3187","DOI":"10.1111\/ene.14983","volume":"28","author":"H Lamothe","year":"2021","unstructured":"Lamothe H, Tamouza R, Hartmann A, Mallet L. Immunity and Gilles De La Tourette syndrome: a systematic review and meta-analysis of evidence for immune implications in Tourette syndrome. Eur J Neurol. 2021;28:3187\u2013200. https:\/\/doi.org\/10.1111\/ene.14983.","journal-title":"Eur J Neurol"},{"key":"830_CR5","first-page":"1","volume-title":"Therapeutic proteins: methods and protocols","author":"DS Dimitrov","year":"2012","unstructured":"Dimitrov DS. Therapeutic proteins. In: Voynov V, Caravella JA, editors. Therapeutic proteins: methods and protocols. Totowa, NJ: Humana Press; 2012. pp. 1\u201326."},{"key":"830_CR6","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.jad.2020.01.125","volume":"266","author":"H Lee","year":"2020","unstructured":"Lee H, Song M, Lee J, Kim JB, Lee MS. Prospective study on cytokine levels in medication-na\u00efve adolescents with first-episode major depressive disorder. J Affect Disord. 2020;266:57\u201362. https:\/\/doi.org\/10.1016\/j.jad.2020.01.125.","journal-title":"J Affect Disord"},{"key":"830_CR7","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1016\/j.jad.2008.07.022","volume":"115","author":"V Gabbay","year":"2009","unstructured":"Gabbay V, Klein RG, Alonso CM, Babb JS, Nishawala M, De Jesus G, et al. Immune system dysregulation in adolescent major depressive disorder. J Affect Disord. 2009;115:177\u201382. https:\/\/doi.org\/10.1016\/j.jad.2008.07.022.","journal-title":"J Affect Disord"},{"key":"830_CR8","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1089\/cap.2019.0015","volume":"29","author":"G D\u2019Acunto","year":"2019","unstructured":"D\u2019Acunto G, Nageye F, Zhang J, Masi G, Cortese S. Inflammatory cytokines in children and adolescents with depressive disorders: a systematic review and Meta-analysis. J Child Adolesc Psychopharmacol. 2019;29:362\u20139. https:\/\/doi.org\/10.1089\/cap.2019.0015.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"830_CR9","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1016\/j.jad.2020.05.158","volume":"274","author":"MH Chen","year":"2020","unstructured":"Chen MH, Kao ZK, Chang WC, Tu PC, Hsu JW, Huang KL, et al. Increased proinflammatory cytokines, executive dysfunction, and reduced Gray Matter volumes in first-episode bipolar disorder and major depressive disorder. J Affect Disord. 2020;274:825\u201331. https:\/\/doi.org\/10.1016\/j.jad.2020.05.158.","journal-title":"J Affect Disord"},{"key":"830_CR10","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1007\/s00787-017-1099-3","volume":"27","author":"R \u00c7olak Sivri","year":"2018","unstructured":"\u00c7olak Sivri R, Bilgi\u00e7 A, K\u0131l\u0131n\u00e7 \u0130. Cytokine, chemokine and BDNF levels in medication-free pediatric patients with obsessive-compulsive disorder. Eur Child Adolesc Psychiatry. 2018;27:977\u201384. https:\/\/doi.org\/10.1007\/s00787-017-1099-3.","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"830_CR11","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1016\/j.brainres.2014.04.027","volume":"1617","author":"D Martino","year":"2015","unstructured":"Martino D, Zis P, Buttiglione M. The role of immune mechanisms in Tourette syndrome. Brain Res. 2015;1617:126\u201343. https:\/\/doi.org\/10.1016\/j.brainres.2014.04.027.","journal-title":"Brain Res"},{"key":"830_CR12","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3233\/ben-120295","volume":"27","author":"I Elamin","year":"2013","unstructured":"Elamin I, Edwards MJ, Martino D. Immune dysfunction in Tourette syndrome. Behav Neurol. 2013;27:23\u201332. https:\/\/doi.org\/10.3233\/ben-120295.","journal-title":"Behav Neurol"},{"key":"830_CR13","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1016\/s0140-6736(04)16942-0","volume":"364","author":"PH Caldwell","year":"2004","unstructured":"Caldwell PH, Murphy SB, Butow PN, Craig JC. Clinical trials in children. Lancet. 2004;364:803\u201311. https:\/\/doi.org\/10.1016\/s0140-6736(04)16942-0.","journal-title":"Lancet"},{"key":"830_CR14","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","volume":"28","author":"JF Leckman","year":"1989","unstructured":"Leckman JF, Riddle MA, Hardin MT, Ort SI, Swartz KL, Stevenson J, et al. The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry. 1989;28:566\u201373.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"830_CR15","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/mds.22504","volume":"24","author":"D Martino","year":"2009","unstructured":"Martino D, Dale RC, Gilbert DL, Giovannoni G, Leckman JF. Immunopathogenic mechanisms in tourette syndrome: a critical review. Mov Disord. 2009;24:1267\u201379. https:\/\/doi.org\/10.1002\/mds.22504.","journal-title":"Mov Disord"},{"key":"830_CR16","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1016\/j.pnpbp.2009.05.001","volume":"33","author":"V Gabbay","year":"2009","unstructured":"Gabbay V, Coffey BJ, Guttman LE, Gottlieb L, Katz Y, Babb JS, et al. A cytokine study in children and adolescents with Tourette\u2019s disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2009;33:967\u201371. https:\/\/doi.org\/10.1016\/j.pnpbp.2009.05.001.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"830_CR17","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1089\/cap.2014.0103","volume":"25","author":"EC Parker-Athill","year":"2015","unstructured":"Parker-Athill EC, Ehrhart J, Tan J, Murphy TK. Cytokine correlations in youth with tic disorders. J Child Adolesc Psychopharmacol. 2015;25:86\u201392. https:\/\/doi.org\/10.1089\/cap.2014.0103.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"830_CR18","doi-asserted-by":"publisher","first-page":"800189","DOI":"10.3389\/fneur.2021.800189","volume":"12","author":"Y Tao","year":"2022","unstructured":"Tao Y, Xu P, Zhu W, Chen Z, Tao X, Liu J, et al. Changes of cytokines in Children with Tic Disorder. Front Neurol. 2022;12:800189. https:\/\/doi.org\/10.3389\/fneur.2021.800189.","journal-title":"Front Neurol"},{"key":"830_CR19","doi-asserted-by":"publisher","first-page":"1390","DOI":"10.1016\/j.pnpbp.2010.06.028","volume":"34","author":"NG Bos-Veneman","year":"2010","unstructured":"Bos-Veneman NG, Bijzet J, Limburg PC, Minderaa RB, Kallenberg CG, Hoekstra PJ. Cytokines and soluble adhesion molecules in children and adolescents with a tic disorder. Prog Neuropsychopharmacol Biol Psychiatry. 2010;34:1390\u20135. https:\/\/doi.org\/10.1016\/j.pnpbp.2010.06.028.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"830_CR20","doi-asserted-by":"publisher","first-page":"2563","DOI":"10.1016\/j.bbamcr.2014.05.014","volume":"1843","author":"MD Turner","year":"2014","unstructured":"Turner MD, Nedjai B, Hurst T, Pennington DJ. Cytokines and chemokines: at the crossroads of cell signalling and inflammatory Disease. Biochim Biophys Acta. 2014;1843:2563\u201382. https:\/\/doi.org\/10.1016\/j.bbamcr.2014.05.014.","journal-title":"Biochim Biophys Acta"},{"key":"830_CR21","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/j.jpsychores.2009.09.002","volume":"67","author":"MH Bloch","year":"2009","unstructured":"Bloch MH, Leckman JF. Clinical course of Tourette syndrome. J Psychosom Res. 2009;67:497\u2013501. https:\/\/doi.org\/10.1016\/j.jpsychores.2009.09.002.","journal-title":"J Psychosom Res"},{"key":"830_CR22","doi-asserted-by":"publisher","first-page":"e034634","DOI":"10.1136\/bmjopen-2019-034634","volume":"10","author":"CS Ho","year":"2020","unstructured":"Ho CS, Huang JY, Yang CH, Lin YJ, Huang MY, Su YC. Is the Yale Global Tic Severity Scale a valid tool for parent-reported assessment in the paediatric population? A prospective observational study in Taiwan. BMJ Open. 2020;10:e034634. https:\/\/doi.org\/10.1136\/bmjopen-2019-034634.","journal-title":"BMJ Open"},{"key":"830_CR23","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1089\/cap.2016.0026","volume":"27","author":"F Sallee","year":"2017","unstructured":"Sallee F, Kohegyi E, Zhao J, McQuade R, Cox K, Sanchez R, et al. Randomized, Double-Blind, placebo-controlled trial demonstrates the efficacy and safety of oral aripiprazole for the treatment of Tourette\u2019s disorder in children and adolescents. J Child Adolesc Psychopharmacol. 2017;27:771\u201381. https:\/\/doi.org\/10.1089\/cap.2016.0026.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"830_CR24","first-page":"67","volume":"17","author":"S Uzun","year":"2005","unstructured":"Uzun S, Kozumplik O, Mimica N, Folnegovi\u0107-Smalc V. Aripiprazole: an overview of a novel antipsychotic. Psychiatria Danubina. 2005;17:67\u201375.","journal-title":"Psychiatria Danubina"},{"key":"830_CR25","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1038\/clpt.1993.146","volume":"54","author":"ML Huang","year":"1993","unstructured":"Huang ML, Peer AV, Woestenborghs R, De Coster R, Heykants J, Jansen AA, et al. Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects. Clin Pharmacol Ther. 1993;54:257\u201368.","journal-title":"Clin Pharmacol Ther"},{"key":"830_CR26","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1089\/cap.1999.9.239","volume":"9","author":"M Wudarsky","year":"1999","unstructured":"Wudarsky M, Nicolson R, Hamburger SD, Spechler L, Gochman P, Bedwell J, et al. Elevated prolactin in pediatric patients on typical and atypical antipsychotics. J Child Adolesc Psychopharmacol. 1999;9:239\u201345.","journal-title":"J Child Adolesc Psychopharmacol"},{"key":"830_CR27","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/S0893-133X(97)00042-0","volume":"17","author":"DD Miller","year":"1997","unstructured":"Miller DD, Andreasen NC, O\u2019Leary DS, Rezai K, Watkins GL, Boles Ponto LL, et al. Effect of antipsychotics on regional cerebral blood flow measured with positron emission tomography. Neuropsychopharmacology. 1997;17:230\u201340.","journal-title":"Neuropsychopharmacology"},{"key":"830_CR28","doi-asserted-by":"publisher","first-page":"1581","DOI":"10.2174\/0929867033457179","volume":"10","author":"B Wirleitner","year":"2003","unstructured":"Wirleitner B, Neurauter G, Schr\u00f6cksnadel K, Frick B, Fuchs D. Interferon-gamma-induced conversion of tryptophan: immunologic and neuropsychiatric aspects. Curr Med Chem. 2003;10:1581\u201391. https:\/\/doi.org\/10.2174\/0929867033457179.","journal-title":"Curr Med Chem"},{"key":"830_CR29","doi-asserted-by":"publisher","first-page":"1554","DOI":"10.1176\/appi.ajp.160.9.1554","volume":"160","author":"CL Raison","year":"2003","unstructured":"Raison CL, Miller AH. When not enough is too much: the role of insufficient glucocorticoid signaling in the pathophysiology of stress-related disorders. Am J Psychiatry. 2003;160:1554\u201365. https:\/\/doi.org\/10.1176\/appi.ajp.160.9.1554.","journal-title":"Am J Psychiatry"},{"key":"830_CR30","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1016\/j.biopsych.2004.12.004","volume":"57","author":"JF Leckman","year":"2005","unstructured":"Leckman JF, Katsovich L, Kawikova I, Lin H, Zhang H, Kr\u00f6nig H, et al. Increased serum levels of interleukin-12 and Tumor necrosis factor-alpha in Tourette\u2019s syndrome. Biol Psychiatry. 2005;57:667\u201373. https:\/\/doi.org\/10.1016\/j.biopsych.2004.12.004.","journal-title":"Biol Psychiatry"},{"key":"830_CR31","doi-asserted-by":"publisher","first-page":"843247","DOI":"10.3389\/fimmu.2022.843247","volume":"13","author":"Y Li","year":"2022","unstructured":"Li Y, Wang X, Yang H, Li Y, Gui J, Cui Y. Profiles of Proinflammatory cytokines and T cells in patients with Tourette Syndrome: a Meta-analysis. Front Immunol. 2022;13:843247. https:\/\/doi.org\/10.3389\/fimmu.2022.843247.","journal-title":"Front Immunol"},{"key":"830_CR32","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1186\/s12974-017-1042-z","volume":"14","author":"N Rodr\u00edguez","year":"2017","unstructured":"Rodr\u00edguez N, Morer A, Gonz\u00e1lez-Navarro EA, Serra-Pages C, Boloc D, Torres T, et al. Inflammatory dysregulation of monocytes in pediatric patients with obsessive-compulsive disorder. J Neuroinflammation. 2017;14:261. https:\/\/doi.org\/10.1186\/s12974-017-1042-z.","journal-title":"J Neuroinflammation"},{"key":"830_CR33","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.psychres.2016.11.005","volume":"247","author":"SM Yeon","year":"2017","unstructured":"Yeon SM, Lee JH, Kang D, Bae H, Lee KY, Jin S, et al. A cytokine study of pediatric Tourette\u2019s disorder without obsessive compulsive disorder. Psychiatry Res. 2017;247:90\u20136. https:\/\/doi.org\/10.1016\/j.psychres.2016.11.005.","journal-title":"Psychiatry Res"}],"container-title":["BMC Neuroscience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-023-00830-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12868-023-00830-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12868-023-00830-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,31]],"date-time":"2023-10-31T06:06:37Z","timestamp":1698732397000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcneurosci.biomedcentral.com\/articles\/10.1186\/s12868-023-00830-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10,31]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["830"],"URL":"https:\/\/doi.org\/10.1186\/s12868-023-00830-3","relation":{},"ISSN":["1471-2202"],"issn-type":[{"value":"1471-2202","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,10,31]]},"assertion":[{"value":"2 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The research processes were approved by the Institutional Review Board (IRB) of the Korea University Guro Hospital (2021GR0275). All research methods were performed in accordance with the relevant guidelines and regulations.Written informed consent was obtained from parents or legal guardians (if parents not available) of all participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"None.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing of interest"}}],"article-number":"57"}}